Aligos Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ALGS for the last quarter is 2.68 M USD, and it's 17.23% lower compared to the previous quarter. The net income of Q4 23 is -27.89 M USD.